These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Maugendre D, Massart C. Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931 [Abstract] [Full Text] [Related]
11. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Takasu N, Kamijo K, Sato Y, Yoshimura H, Nagata A, Ochi Y. Clin Exp Pharmacol Physiol; 2004 Jan; 31(5-6):314-9. PubMed ID: 15191404 [Abstract] [Full Text] [Related]
12. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease. Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J. Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031 [Abstract] [Full Text] [Related]
13. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K. J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336 [Abstract] [Full Text] [Related]
14. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism. Takasu N, Yamashiro K, Ochi Y, Sato Y, Nagata A, Komiya I, Yoshimura H. Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928 [Abstract] [Full Text] [Related]
16. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies. Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A. Acta Med Austriaca; 1996 Apr; 23(1-2):52-6. PubMed ID: 8767515 [Abstract] [Full Text] [Related]
18. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease. Kasagi K, Tamai H, Morita T, Hidaka A, Hatabu H, Misaki T, Iida Y, Ishihara T, Ikekubo K, Kuma K. J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620 [Abstract] [Full Text] [Related]
19. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease. Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N. Endocr J; 2005 Oct; 52(5):505-10. PubMed ID: 16284425 [Abstract] [Full Text] [Related]
20. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease. Hovens GC, Buiting AM, Karperien M, Ballieux BE, van der Pluijm G, Pereira AM, Romijn JA, Smit JW. Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516 [Abstract] [Full Text] [Related] Page: [Next] [New Search]